Claims

Chronic, but not acute, administration of clinical antidepressants enhances adult hippocampal neurogenesis across multiple stages of the neurogenic process

Claim · All claims
Evidence · 1 study · review r2 · q2
Currency · newest study 2022 · not yet checked against its sources · not reviewed by a person · recheck by 2027: baselines and conditions change

Subclaims

Reading the evidence codes

q is the design tier, i the impact, n the sample, and the kind with its r the rigour judged within that kind: what each code means.

This claim: no standardized effect is recorded in observations/ for it yet, so no benchmark reading is possible.

q2 i? Different classes of antidepressants increase cell proliferation and enhance adult hippocampal neurogenesis, an effect requiring chronic rather than acute administration. → Katherine L. Jones 2022

Evidence

Katherine L. Jones 2022

Katherine L. Jones, Mei Zhou and Dhanisha J. Jhaveri. (2022). Dissecting the role of adult hippocampal neurogenesis towards resilience versus susceptibility to stress-related mood disorders. npj Science of Learning 7:16. https://doi.org/10.1038/s41539-022-00133-y

q2 · i? · review · r2

Narrative review citing rodent studies of tranylcypromine, fluoxetine, reboxetine and electroconvulsive therapy, which the review reports increased proliferation and enhanced neurogenesis. The replicated finding is the "requirement of chronic but not acute administration".

"These findings were replicated in several subsequent studies which highlighted the requirement of chronic but not acute administration of these clinical antidepressants to produce the neurogenic effect 56–59."

Discussion

Page metadata
Field Value
status review
generated by process:wiki-ingest on 2026-10-26
trust unverified — no one has confirmed this page's content

Frontmatter is the page's machine-readable record — see the Schema & Guide.